Consistent with previous studies [4,36], our findings confirm an elevated risk of developing cancers in several organs, including the liver, biliary tract, pancreas, breast, corpus uteri, prostate, and kidney, among patients with T2DM
Usage Intravenous or drip administered 1 to 2 times a week for 3 months When the desired result is reached, use once a week for maintenance Precaution Please consult your physician before using this product
Deficiencies can be easily prevented with proper supplementation
By inhibiting DPP-4, these drugs prolong incretin activity, leading to: Glucose-dependent insulin secretion from beta cells Suppression of glucagon from alpha cells Improved postprandial blood glucose control This mechanism does not stimulate insulin release in absence of glucose, making hypoglycemia rare